nodes	percent_of_prediction	percent_of_DWPC	metapath
Nicotine—CYP19A1—polycystic ovary syndrome	0.251	0.576	CbGaD
Nicotine—CYP1A1—polycystic ovary syndrome	0.185	0.424	CbGaD
Nicotine—SLC22A3—Metformin—polycystic ovary syndrome	0.142	0.475	CbGbCtD
Nicotine—SLC22A2—Metformin—polycystic ovary syndrome	0.0842	0.281	CbGbCtD
Nicotine—SLC22A1—Metformin—polycystic ovary syndrome	0.0732	0.244	CbGbCtD
Nicotine—CYP19A1—follicular fluid—polycystic ovary syndrome	0.0113	0.0978	CbGeAlD
Nicotine—CHRFAM7A—corpus luteum—polycystic ovary syndrome	0.0103	0.089	CbGeAlD
Nicotine—CHRNA7—corpus luteum—polycystic ovary syndrome	0.00832	0.0719	CbGeAlD
Nicotine—CHRFAM7A—ovarian follicle—polycystic ovary syndrome	0.00806	0.0696	CbGeAlD
Nicotine—CYP19A1—corpus luteum—polycystic ovary syndrome	0.00652	0.0563	CbGeAlD
Nicotine—CHRNA7—ovarian follicle—polycystic ovary syndrome	0.00651	0.0562	CbGeAlD
Nicotine—Abnormal faeces—Metformin—polycystic ovary syndrome	0.0053	0.113	CcSEcCtD
Nicotine—CYP19A1—ovarian follicle—polycystic ovary syndrome	0.0051	0.0441	CbGeAlD
Nicotine—CHRNA9—embryo—polycystic ovary syndrome	0.00438	0.0378	CbGeAlD
Nicotine—Toothache—Metformin—polycystic ovary syndrome	0.00249	0.0532	CcSEcCtD
Nicotine—Heartburn—Metformin—polycystic ovary syndrome	0.0022	0.047	CcSEcCtD
Nicotine—CYP2A13—endocrine gland—polycystic ovary syndrome	0.00191	0.0165	CbGeAlD
Nicotine—Rhinorrhoea—Metformin—polycystic ovary syndrome	0.00187	0.04	CcSEcCtD
Nicotine—CHRNA5—vagina—polycystic ovary syndrome	0.00175	0.0151	CbGeAlD
Nicotine—CYP2C19—urine—polycystic ovary syndrome	0.00175	0.0151	CbGeAlD
Nicotine—Chest discomfort—Metformin—polycystic ovary syndrome	0.00171	0.0366	CcSEcCtD
Nicotine—CYP1A2—urine—polycystic ovary syndrome	0.00143	0.0123	CbGeAlD
Nicotine—CYP2C9—urine—polycystic ovary syndrome	0.00136	0.0117	CbGeAlD
Nicotine—CHRNB4—adrenal gland—polycystic ovary syndrome	0.0013	0.0112	CbGeAlD
Nicotine—Ear pain—Metformin—polycystic ovary syndrome	0.00129	0.0275	CcSEcCtD
Nicotine—CYP2E1—urine—polycystic ovary syndrome	0.00129	0.0111	CbGeAlD
Nicotine—Nasal congestion—Metformin—polycystic ovary syndrome	0.00121	0.0258	CcSEcCtD
Nicotine—CHRNB2—adrenal cortex—polycystic ovary syndrome	0.00114	0.00984	CbGeAlD
Nicotine—Migraine—Metformin—polycystic ovary syndrome	0.00108	0.0231	CcSEcCtD
Nicotine—CHRNA10—vagina—polycystic ovary syndrome	0.00106	0.00916	CbGeAlD
Nicotine—CYP3A4—urine—polycystic ovary syndrome	0.00103	0.00894	CbGeAlD
Nicotine—CHAT—endocrine gland—polycystic ovary syndrome	0.00103	0.0089	CbGeAlD
Nicotine—CYP2D6—urine—polycystic ovary syndrome	0.00102	0.00879	CbGeAlD
Nicotine—CHRNB2—endometrium—polycystic ovary syndrome	0.00102	0.00878	CbGeAlD
Nicotine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.001	0.0215	CcSEcCtD
Nicotine—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.000984	0.021	CcSEcCtD
Nicotine—Influenza—Metformin—polycystic ovary syndrome	0.000951	0.0203	CcSEcCtD
Nicotine—CHRNB2—uterus—polycystic ovary syndrome	0.000937	0.00809	CbGeAlD
Nicotine—Sweating increased—Metformin—polycystic ovary syndrome	0.000926	0.0198	CcSEcCtD
Nicotine—CHRNB2—pituitary gland—polycystic ovary syndrome	0.00092	0.00795	CbGeAlD
Nicotine—CHRNB2—adipose tissue—polycystic ovary syndrome	0.000916	0.00792	CbGeAlD
Nicotine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.000912	0.0195	CcSEcCtD
Nicotine—CHRNB2—adrenal gland—polycystic ovary syndrome	0.000822	0.0071	CbGeAlD
Nicotine—CHRNA3—adrenal gland—polycystic ovary syndrome	0.000797	0.00689	CbGeAlD
Nicotine—CHRNB2—female gonad—polycystic ovary syndrome	0.000766	0.00662	CbGeAlD
Nicotine—Rhinitis—Metformin—polycystic ovary syndrome	0.000763	0.0163	CcSEcCtD
Nicotine—CHRNB2—vagina—polycystic ovary syndrome	0.000762	0.00658	CbGeAlD
Nicotine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.000757	0.0162	CcSEcCtD
Nicotine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00075	0.016	CcSEcCtD
Nicotine—Flushing—Metformin—polycystic ovary syndrome	0.000706	0.0151	CcSEcCtD
Nicotine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.000706	0.0151	CcSEcCtD
Nicotine—SLC22A3—embryo—polycystic ovary syndrome	0.000701	0.00606	CbGeAlD
Nicotine—CHRNA3—endocrine gland—polycystic ovary syndrome	0.000691	0.00597	CbGeAlD
Nicotine—Immune system disorder—Metformin—polycystic ovary syndrome	0.000687	0.0147	CcSEcCtD
Nicotine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.000686	0.0147	CcSEcCtD
Nicotine—Erythema—Metformin—polycystic ovary syndrome	0.000663	0.0142	CcSEcCtD
Nicotine—Flatulence—Metformin—polycystic ovary syndrome	0.000653	0.0139	CcSEcCtD
Nicotine—MAOB—embryo—polycystic ovary syndrome	0.000649	0.00561	CbGeAlD
Nicotine—Dysgeusia—Metformin—polycystic ovary syndrome	0.000649	0.0139	CcSEcCtD
Nicotine—CHRNA2—endocrine gland—polycystic ovary syndrome	0.000643	0.00555	CbGeAlD
Nicotine—Muscle spasms—Metformin—polycystic ovary syndrome	0.000637	0.0136	CcSEcCtD
Nicotine—Tremor—Metformin—polycystic ovary syndrome	0.000621	0.0133	CcSEcCtD
Nicotine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000615	0.0131	CcSEcCtD
Nicotine—CHRFAM7A—female gonad—polycystic ovary syndrome	0.000601	0.00519	CbGeAlD
Nicotine—Malaise—Metformin—polycystic ovary syndrome	0.000597	0.0128	CcSEcCtD
Nicotine—Syncope—Metformin—polycystic ovary syndrome	0.000594	0.0127	CcSEcCtD
Nicotine—CHRNA7—uterus—polycystic ovary syndrome	0.000594	0.00513	CbGeAlD
Nicotine—Palpitations—Metformin—polycystic ovary syndrome	0.000585	0.0125	CcSEcCtD
Nicotine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000582	0.0124	CcSEcCtD
Nicotine—CYP2A6—adipose tissue—polycystic ovary syndrome	0.00058	0.00501	CbGeAlD
Nicotine—Hypertension—Metformin—polycystic ovary syndrome	0.000572	0.0122	CcSEcCtD
Nicotine—Myalgia—Metformin—polycystic ovary syndrome	0.000564	0.012	CcSEcCtD
Nicotine—Chest pain—Metformin—polycystic ovary syndrome	0.000564	0.012	CcSEcCtD
Nicotine—SLC22A4—endometrium—polycystic ovary syndrome	0.000564	0.00487	CbGeAlD
Nicotine—CHRFAM7A—endocrine gland—polycystic ovary syndrome	0.000559	0.00483	CbGeAlD
Nicotine—Discomfort—Metformin—polycystic ovary syndrome	0.000557	0.0119	CcSEcCtD
Nicotine—MAOA—embryo—polycystic ovary syndrome	0.000554	0.00478	CbGeAlD
Nicotine—Oedema—Metformin—polycystic ovary syndrome	0.000541	0.0115	CcSEcCtD
Nicotine—Shock—Metformin—polycystic ovary syndrome	0.000532	0.0114	CcSEcCtD
Nicotine—MAOB—adrenal cortex—polycystic ovary syndrome	0.000532	0.00459	CbGeAlD
Nicotine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00053	0.0113	CcSEcCtD
Nicotine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000523	0.0112	CcSEcCtD
Nicotine—CHRNA7—adrenal gland—polycystic ovary syndrome	0.000521	0.0045	CbGeAlD
Nicotine—CHRNA4—adrenal gland—polycystic ovary syndrome	0.000514	0.00444	CbGeAlD
Nicotine—SLC22A3—endometrium—polycystic ovary syndrome	0.000513	0.00443	CbGeAlD
Nicotine—SLC22A4—pituitary gland—polycystic ovary syndrome	0.00051	0.00441	CbGeAlD
Nicotine—SLC22A4—adipose tissue—polycystic ovary syndrome	0.000508	0.00439	CbGeAlD
Nicotine—Hypotension—Metformin—polycystic ovary syndrome	0.000505	0.0108	CcSEcCtD
Nicotine—CYP19A1—endometrium—polycystic ovary syndrome	0.000505	0.00436	CbGeAlD
Nicotine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000493	0.0105	CcSEcCtD
Nicotine—CHRNA7—female gonad—polycystic ovary syndrome	0.000486	0.00419	CbGeAlD
Nicotine—Paraesthesia—Metformin—polycystic ovary syndrome	0.000486	0.0104	CcSEcCtD
Nicotine—SLC22A1—adipose tissue—polycystic ovary syndrome	0.000484	0.00418	CbGeAlD
Nicotine—CYP2A6—vagina—polycystic ovary syndrome	0.000482	0.00417	CbGeAlD
Nicotine—Dyspnoea—Metformin—polycystic ovary syndrome	0.000482	0.0103	CcSEcCtD
Nicotine—Somnolence—Metformin—polycystic ovary syndrome	0.000481	0.0103	CcSEcCtD
Nicotine—Dyspepsia—Metformin—polycystic ovary syndrome	0.000476	0.0102	CcSEcCtD
Nicotine—MAOB—endometrium—polycystic ovary syndrome	0.000475	0.0041	CbGeAlD
Nicotine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000467	0.00997	CcSEcCtD
Nicotine—Fatigue—Metformin—polycystic ovary syndrome	0.000466	0.00996	CcSEcCtD
Nicotine—CYP19A1—uterus—polycystic ovary syndrome	0.000465	0.00402	CbGeAlD
Nicotine—SLC22A3—adipose tissue—polycystic ovary syndrome	0.000463	0.004	CbGeAlD
Nicotine—Constipation—Metformin—polycystic ovary syndrome	0.000462	0.00988	CcSEcCtD
Nicotine—SLC22A4—adrenal gland—polycystic ovary syndrome	0.000456	0.00394	CbGeAlD
Nicotine—CYP19A1—adipose tissue—polycystic ovary syndrome	0.000455	0.00393	CbGeAlD
Nicotine—MAOA—adrenal cortex—polycystic ovary syndrome	0.000454	0.00392	CbGeAlD
Nicotine—CHRNA7—endocrine gland—polycystic ovary syndrome	0.000452	0.0039	CbGeAlD
Nicotine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000446	0.00952	CcSEcCtD
Nicotine—CHRNA4—endocrine gland—polycystic ovary syndrome	0.000445	0.00385	CbGeAlD
Nicotine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000442	0.00944	CcSEcCtD
Nicotine—MAOB—uterus—polycystic ovary syndrome	0.000438	0.00378	CbGeAlD
Nicotine—MAOB—pituitary gland—polycystic ovary syndrome	0.00043	0.00371	CbGeAlD
Nicotine—Urticaria—Metformin—polycystic ovary syndrome	0.00043	0.00917	CcSEcCtD
Nicotine—MAOB—adipose tissue—polycystic ovary syndrome	0.000428	0.0037	CbGeAlD
Nicotine—Abdominal pain—Metformin—polycystic ovary syndrome	0.000427	0.00913	CcSEcCtD
Nicotine—SLC22A4—vagina—polycystic ovary syndrome	0.000423	0.00365	CbGeAlD
Nicotine—SLC22A5—adrenal cortex—polycystic ovary syndrome	0.000418	0.00361	CbGeAlD
Nicotine—SLC22A3—adrenal gland—polycystic ovary syndrome	0.000415	0.00358	CbGeAlD
Nicotine—CYP19A1—adrenal gland—polycystic ovary syndrome	0.000408	0.00352	CbGeAlD
Nicotine—MAOA—endometrium—polycystic ovary syndrome	0.000405	0.0035	CbGeAlD
Nicotine—SLC22A1—vagina—polycystic ovary syndrome	0.000402	0.00348	CbGeAlD
Nicotine—Asthenia—Metformin—polycystic ovary syndrome	0.000388	0.00829	CcSEcCtD
Nicotine—SLC22A3—female gonad—polycystic ovary syndrome	0.000387	0.00334	CbGeAlD
Nicotine—SLC22A3—vagina—polycystic ovary syndrome	0.000385	0.00332	CbGeAlD
Nicotine—MAOB—adrenal gland—polycystic ovary syndrome	0.000384	0.00332	CbGeAlD
Nicotine—Pruritus—Metformin—polycystic ovary syndrome	0.000383	0.00817	CcSEcCtD
Nicotine—CYP19A1—female gonad—polycystic ovary syndrome	0.00038	0.00329	CbGeAlD
Nicotine—SLC22A1—endocrine gland—polycystic ovary syndrome	0.000377	0.00325	CbGeAlD
Nicotine—MAOA—uterus—polycystic ovary syndrome	0.000373	0.00323	CbGeAlD
Nicotine—SLC22A5—endometrium—polycystic ovary syndrome	0.000373	0.00322	CbGeAlD
Nicotine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00037	0.0079	CcSEcCtD
Nicotine—MAOA—pituitary gland—polycystic ovary syndrome	0.000367	0.00317	CbGeAlD
Nicotine—MAOA—adipose tissue—polycystic ovary syndrome	0.000365	0.00315	CbGeAlD
Nicotine—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000363	0.00314	CbGeAlD
Nicotine—CYP2C8—endometrium—polycystic ovary syndrome	0.000361	0.00312	CbGeAlD
Nicotine—SLC22A3—endocrine gland—polycystic ovary syndrome	0.00036	0.00311	CbGeAlD
Nicotine—MAOB—female gonad—polycystic ovary syndrome	0.000358	0.00309	CbGeAlD
Nicotine—Dizziness—Metformin—polycystic ovary syndrome	0.000358	0.00764	CcSEcCtD
Nicotine—MAOB—vagina—polycystic ovary syndrome	0.000356	0.00307	CbGeAlD
Nicotine—CYP19A1—endocrine gland—polycystic ovary syndrome	0.000354	0.00306	CbGeAlD
Nicotine—Vomiting—Metformin—polycystic ovary syndrome	0.000344	0.00734	CcSEcCtD
Nicotine—Rash—Metformin—polycystic ovary syndrome	0.000341	0.00728	CcSEcCtD
Nicotine—Dermatitis—Metformin—polycystic ovary syndrome	0.000341	0.00728	CcSEcCtD
Nicotine—Headache—Metformin—polycystic ovary syndrome	0.000339	0.00724	CcSEcCtD
Nicotine—SLC22A5—pituitary gland—polycystic ovary syndrome	0.000338	0.00292	CbGeAlD
Nicotine—SLC22A5—adipose tissue—polycystic ovary syndrome	0.000336	0.00291	CbGeAlD
Nicotine—MAOB—endocrine gland—polycystic ovary syndrome	0.000333	0.00288	CbGeAlD
Nicotine—MAOA—adrenal gland—polycystic ovary syndrome	0.000328	0.00283	CbGeAlD
Nicotine—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000327	0.00282	CbGeAlD
Nicotine—Nausea—Metformin—polycystic ovary syndrome	0.000321	0.00686	CcSEcCtD
Nicotine—CYP2C19—vagina—polycystic ovary syndrome	0.00031	0.00268	CbGeAlD
Nicotine—CYP1A1—uterus—polycystic ovary syndrome	0.000307	0.00265	CbGeAlD
Nicotine—MAOA—female gonad—polycystic ovary syndrome	0.000305	0.00264	CbGeAlD
Nicotine—MAOA—vagina—polycystic ovary syndrome	0.000304	0.00262	CbGeAlD
Nicotine—SLC22A5—adrenal gland—polycystic ovary syndrome	0.000302	0.00261	CbGeAlD
Nicotine—CYP1A1—adipose tissue—polycystic ovary syndrome	0.000301	0.0026	CbGeAlD
Nicotine—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00029	0.00251	CbGeAlD
Nicotine—MAOA—endocrine gland—polycystic ovary syndrome	0.000284	0.00245	CbGeAlD
Nicotine—SLC22A5—female gonad—polycystic ovary syndrome	0.000281	0.00243	CbGeAlD
Nicotine—SLC22A5—vagina—polycystic ovary syndrome	0.00028	0.00242	CbGeAlD
Nicotine—CYP2C8—vagina—polycystic ovary syndrome	0.000271	0.00234	CbGeAlD
Nicotine—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000262	0.00226	CbGeAlD
Nicotine—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000253	0.00219	CbGeAlD
Nicotine—CYP1A1—female gonad—polycystic ovary syndrome	0.000251	0.00217	CbGeAlD
Nicotine—CYP1A1—vagina—polycystic ovary syndrome	0.00025	0.00216	CbGeAlD
Nicotine—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000246	0.00212	CbGeAlD
Nicotine—CYP2B6—vagina—polycystic ovary syndrome	0.000243	0.0021	CbGeAlD
Nicotine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000237	0.00205	CbGeAlD
Nicotine—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000234	0.00202	CbGeAlD
Nicotine—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000227	0.00196	CbGeAlD
Nicotine—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000225	0.00194	CbGeAlD
Nicotine—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000213	0.00184	CbGeAlD
Nicotine—CYP2D6—female gonad—polycystic ovary syndrome	0.000182	0.00157	CbGeAlD
Nicotine—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000172	0.00148	CbGeAlD
Nicotine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000169	0.00146	CbGeAlD
Nicotine—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	9.25e-06	9.13e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	9.17e-06	9.06e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—RRM2—polycystic ovary syndrome	9.14e-06	9.03e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	9.1e-06	8.98e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—TH—polycystic ovary syndrome	9.08e-06	8.97e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	8.98e-06	8.87e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	8.97e-06	8.85e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	8.95e-06	8.84e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.88e-06	8.76e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—SLC2A4—polycystic ovary syndrome	8.83e-06	8.72e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—YAP1—polycystic ovary syndrome	8.81e-06	8.7e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—GNAS—polycystic ovary syndrome	8.77e-06	8.65e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SULT2A1—polycystic ovary syndrome	8.72e-06	8.61e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	8.68e-06	8.57e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	8.66e-06	8.55e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	8.63e-06	8.52e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	8.63e-06	8.52e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	8.58e-06	8.47e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—GNAS—polycystic ovary syndrome	8.55e-06	8.44e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NAMPT—polycystic ovary syndrome	8.47e-06	8.36e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—TH—polycystic ovary syndrome	8.46e-06	8.36e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—RRM2—polycystic ovary syndrome	8.44e-06	8.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	8.41e-06	8.31e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	8.38e-06	8.27e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	8.38e-06	8.27e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP11A1—polycystic ovary syndrome	8.36e-06	8.26e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—NCOR1—polycystic ovary syndrome	8.35e-06	8.24e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—TH—polycystic ovary syndrome	8.34e-06	8.23e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP19A1—polycystic ovary syndrome	8.31e-06	8.2e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	8.29e-06	8.19e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	8.26e-06	8.15e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—SLC2A4—polycystic ovary syndrome	8.23e-06	8.13e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	8.23e-06	8.12e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	8.19e-06	8.09e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	8.19e-06	8.08e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	8.19e-06	8.08e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—NCOR1—polycystic ovary syndrome	8.15e-06	8.04e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—YAP1—polycystic ovary syndrome	8.14e-06	8.03e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.13e-06	8.03e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—SLC2A4—polycystic ovary syndrome	8.11e-06	8.01e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	8.09e-06	7.99e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—PPARG—polycystic ovary syndrome	8.07e-06	7.97e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	8e-06	7.9e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	7.99e-06	7.89e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—POMC—polycystic ovary syndrome	7.96e-06	7.86e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—CYP1A1—polycystic ovary syndrome	7.92e-06	7.82e-05	CbGpPWpGaD
Nicotine—SLC22A3—Metabolism—INS—polycystic ovary syndrome	7.91e-06	7.81e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—AKR1C3—polycystic ovary syndrome	7.9e-06	7.8e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NAMPT—polycystic ovary syndrome	7.82e-06	7.72e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	7.77e-06	7.67e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.77e-06	7.67e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	7.75e-06	7.65e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.74e-06	7.64e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	7.74e-06	7.64e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	7.73e-06	7.64e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—CYP1A1—polycystic ovary syndrome	7.72e-06	7.62e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	7.72e-06	7.62e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.67e-06	7.57e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.67e-06	7.57e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP19A1—polycystic ovary syndrome	7.62e-06	7.53e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	7.61e-06	7.52e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	7.53e-06	7.44e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	7.47e-06	7.37e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	7.46e-06	7.37e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—GNAS—polycystic ovary syndrome	7.41e-06	7.32e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—MTHFR—polycystic ovary syndrome	7.38e-06	7.29e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	7.36e-06	7.27e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	7.33e-06	7.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	7.3e-06	7.2e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	7.29e-06	7.2e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—MTHFR—polycystic ovary syndrome	7.2e-06	7.11e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	7.18e-06	7.09e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	7.17e-06	7.08e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	7.13e-06	7.04e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	7.13e-06	7.04e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.13e-06	7.04e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	7.08e-06	6.99e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	7.07e-06	6.98e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—NCOR1—polycystic ovary syndrome	7.06e-06	6.97e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.03e-06	6.94e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	7.02e-06	6.93e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	7e-06	6.91e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.92e-06	6.83e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—GNAS—polycystic ovary syndrome	6.91e-06	6.82e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	6.91e-06	6.82e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—GNAS—polycystic ovary syndrome	6.81e-06	6.72e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—TH—polycystic ovary syndrome	6.73e-06	6.64e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—CYP1A1—polycystic ovary syndrome	6.69e-06	6.61e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	6.69e-06	6.6e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	6.66e-06	6.57e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	6.66e-06	6.57e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—TH—polycystic ovary syndrome	6.59e-06	6.5e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—NCOR1—polycystic ovary syndrome	6.58e-06	6.5e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	6.58e-06	6.5e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	6.56e-06	6.48e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.56e-06	6.47e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	6.54e-06	6.46e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	6.5e-06	6.42e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—NCOR1—polycystic ovary syndrome	6.48e-06	6.4e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	6.41e-06	6.33e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	6.4e-06	6.32e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	6.38e-06	6.3e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	6.36e-06	6.28e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	6.35e-06	6.27e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	6.35e-06	6.27e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	6.32e-06	6.24e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	6.3e-06	6.22e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	6.27e-06	6.19e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—MTHFR—polycystic ovary syndrome	6.24e-06	6.16e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—CYP1A1—polycystic ovary syndrome	6.24e-06	6.16e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	6.24e-06	6.16e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—TH—polycystic ovary syndrome	6.21e-06	6.13e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	6.15e-06	6.07e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—CYP1A1—polycystic ovary syndrome	6.15e-06	6.07e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	6.13e-06	6.05e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	6.07e-06	5.99e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	6.04e-06	5.97e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	6.04e-06	5.96e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	6.03e-06	5.95e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—PPARG—polycystic ovary syndrome	5.98e-06	5.91e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	5.97e-06	5.89e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—POMC—polycystic ovary syndrome	5.9e-06	5.83e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	5.88e-06	5.81e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	5.87e-06	5.8e-05	CbGpPWpGaD
Nicotine—MAOA—Metabolism—INS—polycystic ovary syndrome	5.87e-06	5.79e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—PPARG—polycystic ovary syndrome	5.84e-06	5.76e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	5.83e-06	5.76e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—MTHFR—polycystic ovary syndrome	5.82e-06	5.74e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	5.81e-06	5.74e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.8e-06	5.73e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	5.76e-06	5.69e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—POMC—polycystic ovary syndrome	5.76e-06	5.68e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—MTHFR—polycystic ovary syndrome	5.73e-06	5.66e-05	CbGpPWpGaD
Nicotine—CYP19A1—Metabolism—INS—polycystic ovary syndrome	5.73e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.72e-06	5.65e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—TH—polycystic ovary syndrome	5.69e-06	5.62e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	5.68e-06	5.61e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	5.66e-06	5.59e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	5.56e-06	5.49e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	5.54e-06	5.47e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	5.49e-06	5.42e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	5.49e-06	5.42e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	5.44e-06	5.37e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	5.4e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	5.4e-06	5.33e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	5.38e-06	5.31e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	5.38e-06	5.31e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	5.36e-06	5.29e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	5.23e-06	5.16e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	5.21e-06	5.14e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	5.19e-06	5.12e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	5.12e-06	5.06e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—TH—polycystic ovary syndrome	5.08e-06	5.02e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	5.07e-06	5.01e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—PPARG—polycystic ovary syndrome	5.06e-06	5e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—POMC—polycystic ovary syndrome	4.99e-06	4.93e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	4.99e-06	4.92e-05	CbGpPWpGaD
Nicotine—SLC22A2—Metabolism—INS—polycystic ovary syndrome	4.96e-06	4.9e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	4.96e-06	4.9e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.96e-06	4.89e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	4.94e-06	4.88e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	4.92e-06	4.86e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	4.92e-06	4.86e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.89e-06	4.83e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	4.86e-06	4.8e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	4.83e-06	4.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	4.81e-06	4.75e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—PPARG—polycystic ovary syndrome	4.72e-06	4.66e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	4.68e-06	4.62e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	4.66e-06	4.6e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—POMC—polycystic ovary syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—PPARG—polycystic ovary syndrome	4.65e-06	4.59e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—TH—polycystic ovary syndrome	4.63e-06	4.58e-05	CbGpPWpGaD
Nicotine—SLC22A1—Metabolism—INS—polycystic ovary syndrome	4.63e-06	4.57e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	4.62e-06	4.56e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—POMC—polycystic ovary syndrome	4.58e-06	4.52e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	4.58e-06	4.52e-05	CbGpPWpGaD
Nicotine—CYP2A6—Metabolism—INS—polycystic ovary syndrome	4.56e-06	4.5e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	4.55e-06	4.49e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	4.53e-06	4.47e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	4.51e-06	4.45e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	4.43e-06	4.37e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	4.29e-06	4.23e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	4.28e-06	4.22e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	4.27e-06	4.21e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	4.24e-06	4.18e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	4.2e-06	4.14e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	4.15e-06	4.1e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	4.15e-06	4.1e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	4e-06	3.95e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	3.96e-06	3.91e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	3.95e-06	3.9e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	3.91e-06	3.86e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	3.85e-06	3.8e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	3.85e-06	3.8e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	3.82e-06	3.77e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	3.8e-06	3.75e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	3.78e-06	3.74e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	3.75e-06	3.7e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	3.75e-06	3.7e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	3.7e-06	3.65e-05	CbGpPWpGaD
Nicotine—CYP2B6—Metabolism—INS—polycystic ovary syndrome	3.68e-06	3.63e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	3.67e-06	3.62e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	3.64e-06	3.59e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	3.62e-06	3.58e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	3.62e-06	3.58e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	3.6e-06	3.56e-05	CbGpPWpGaD
Nicotine—CYP2E1—Metabolism—INS—polycystic ovary syndrome	3.6e-06	3.56e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	3.59e-06	3.54e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	3.53e-06	3.49e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	3.49e-06	3.45e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	3.46e-06	3.42e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	3.45e-06	3.4e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	3.42e-06	3.37e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	3.41e-06	3.37e-05	CbGpPWpGaD
Nicotine—CYP1A1—Metabolism—INS—polycystic ovary syndrome	3.4e-06	3.35e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	3.23e-06	3.19e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	3.21e-06	3.17e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	3.19e-06	3.14e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	3.17e-06	3.13e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	3.13e-06	3.09e-05	CbGpPWpGaD
Nicotine—CYP2C8—Metabolism—INS—polycystic ovary syndrome	3.11e-06	3.07e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	3.08e-06	3.04e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.06e-06	3.02e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.97e-06	2.94e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.92e-06	2.88e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.83e-06	2.8e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.8e-06	2.76e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.79e-06	2.76e-05	CbGpPWpGaD
Nicotine—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.78e-06	2.74e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.72e-06	2.69e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	2.61e-06	2.57e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	2.58e-06	2.55e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	2.57e-06	2.54e-05	CbGpPWpGaD
Nicotine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	2.56e-06	2.52e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	2.55e-06	2.52e-05	CbGpPWpGaD
Nicotine—CYP2C9—Metabolism—INS—polycystic ovary syndrome	2.53e-06	2.5e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	2.5e-06	2.46e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	2.38e-06	2.35e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.25e-06	2.22e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	2.21e-06	2.18e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	2.18e-06	2.15e-05	CbGpPWpGaD
Nicotine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	2.16e-06	2.14e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.1e-06	2.07e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.7e-06	1.68e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.68e-06	1.66e-05	CbGpPWpGaD
Nicotine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.67e-06	1.65e-05	CbGpPWpGaD
